Skip to main content

Advertisement

Peer Review reports

From: Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial

Original Submission
30 Jan 2017 Submitted Original manuscript
24 Feb 2017 Author responded Author comments - Víctor Pérez
Resubmission - Version 2
24 Feb 2017 Submitted Manuscript version 2
13 Mar 2017 Reviewed Reviewer Report - Chad Bousman
23 Mar 2017 Reviewed Reviewer Report - Jeffrey Bishop
27 Mar 2017 Reviewed Reviewer Report - Eva Brandl
27 Mar 2017 Reviewed Reviewer Report - Jian-Ping Zhang
27 Apr 2017 Author responded Author comments - Víctor Pérez
Resubmission - Version 3
27 Apr 2017 Submitted Manuscript version 3
1 May 2017 Reviewed Reviewer Report - Chad Bousman
23 May 2017 Reviewed Reviewer Report - Jeffrey Bishop
24 May 2017 Reviewed Reviewer Report - Eva Brandl
26 May 2017 Reviewed Reviewer Report - Jian-Ping Zhang
12 Jun 2017 Author responded Author comments - Víctor Pérez
Resubmission - Version 4
12 Jun 2017 Submitted Manuscript version 4
26 Jun 2017 Author responded Author comments - Víctor Pérez
Resubmission - Version 5
26 Jun 2017 Submitted Manuscript version 5
Publishing
29 Jun 2017 Editorially accepted
14 Jul 2017 Article published 10.1186/s12888-017-1412-1

You can find further information about peer review here.

Back to article page